RXD vs. IHE
RXD (ProShares UltraShort Health Care) and IHE (iShares U.S. Pharmaceuticals ETF) are both exchange-traded funds - RXD is a Leveraged Equities fund tracking the DJ Global United States (All) / Health Care -IND (-200%), while IHE is a Health & Biotech Equities fund tracking the Dow Jones U.S. Select Pharmaceuticals Index. Both are passively managed. Over the past 10 years, RXD returned -20.50%/yr vs 9.50%/yr for IHE. At a correlation of -0.77, they often move in opposite directions. RXD charges 0.95%/yr vs 0.42%/yr for IHE.
Performance
RXD vs. IHE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RXD achieves a -1.40% return, which is significantly lower than IHE's 13.81% return. Over the past 10 years, RXD has underperformed IHE with an annualized return of -20.50%, while IHE has yielded a comparatively higher 9.50% annualized return.
RXD
- 1D
- -3.08%
- 1M
- -9.66%
- YTD
- -1.40%
- 6M
- 0.04%
- 1Y
- -25.85%
- 3Y*
- -8.16%
- 5Y*
- -7.55%
- 10Y*
- -20.50%
IHE
- 1D
- 0.90%
- 1M
- 5.53%
- YTD
- 13.81%
- 6M
- 11.99%
- 1Y
- 48.10%
- 3Y*
- 19.70%
- 5Y*
- 10.84%
- 10Y*
- 9.50%
RXD vs. IHE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RXD ProShares UltraShort Health Care | -1.40% | -21.66% | 4.83% | 3.25% | 1.20% | -37.97% | -44.25% | -32.44% | -14.33% | -35.24% |
IHE iShares U.S. Pharmaceuticals ETF | 13.81% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 13.66% | 15.47% | -7.76% | 10.64% |
Correlation
The correlation between RXD and IHE is -0.85, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.85 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.83 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.84 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.78 |
Correlation (All Time) Calculated using the full available price history since Feb 1, 2007 | -0.77 |
The correlation between RXD and IHE has been stable across timeframes, ranging from -0.85 to -0.77 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RXD vs. IHE — Risk / Return Rank
RXD
IHE
RXD vs. IHE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Health Care (RXD) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RXD | IHE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.66 | ||
| Sortino ratioReturn per unit of downside risk | -5.10 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.47 | -0.60 |
| Calmar ratioReturn relative to maximum drawdown | -0.75 | 5.70 | -6.45 |
| Martin ratioReturn relative to average drawdown | -1.12 | 17.54 | -18.66 |
Loading charts...
Drawdowns
RXD vs. IHE - Drawdown Comparison
The maximum RXD drawdown since its inception was -99.65%, which is greater than IHE's maximum drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for RXD and IHE.
Loading charts...
Drawdown Indicators
| RXD | IHE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.65% | -38.20% | -61.45% |
Max Drawdown (1Y)Largest decline over 1 year | -34.63% | -8.47% | -26.16% |
Max Drawdown (3Y)Largest decline over 3 years | -36.60% | -15.92% | -20.68% |
Max Drawdown (5Y)Largest decline over 5 years | -40.50% | -16.03% | -24.47% |
Max Drawdown (10Y)Largest decline over 10 years | -90.64% | -29.59% | -61.05% |
Current DrawdownCurrent decline from peak | -99.63% | 0.00% | -99.63% |
Average DrawdownAverage peak-to-trough decline | -81.91% | -7.90% | -74.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.10% | 2.75% | +20.35% |
Volatility
RXD vs. IHE - Volatility Comparison
ProShares UltraShort Health Care (RXD) has a higher volatility of 10.55% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 5.26%. This indicates that RXD's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RXD | IHE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.55% | 5.26% | +5.29% |
Volatility (6M)Calculated over the trailing 6-month period | 21.92% | 12.69% | +9.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.33% | 17.23% | +13.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.91% | 16.29% | +13.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.01% | 18.04% | +14.97% |
RXD vs. IHE - Expense Ratio Comparison
RXD has a 0.95% expense ratio, which is higher than IHE's 0.42% expense ratio.
Dividends
RXD vs. IHE - Dividend Comparison
RXD's dividend yield for the trailing twelve months is around 3.01%, more than IHE's 1.53% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 1.53% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
RXD ProShares UltraShort Health Care | 3.01% | 3.29% | 4.36% | 3.17% | 0.67% | 0.00% | 0.17% | 1.73% | 0.22% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
RXD and IHE have a correlation of -0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RXD has higher volatility (10.55%) compared to IHE (5.26%). In terms of maximum drawdown, RXD dropped -99.65% vs IHE's -38.20%.
On 10-year performance, IHE leads with 9.50% vs -20.50% for RXD. On fees, IHE is cheaper at 0.42% per year. On volatility, IHE has been the lower-risk option at 5.26%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, IHE has performed better with a 9.50% return vs -20.50%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IHE is cheaper with a 0.42% expense ratio, compared with 0.95% for RXD.
RXD has the higher dividend yield at 3.01%, compared with 1.53% for IHE.
RXD is categorized as Leveraged Equities, while IHE is Health & Biotech Equities. RXD tracks DJ Global United States (All) / Health Care -IND (-200%), while IHE tracks Dow Jones U.S. Select Pharmaceuticals Index. They also come from different issuers: ProShares and iShares. Their fees differ too: 0.95% for RXD and 0.42% for IHE.
IHE currently has the higher Sharpe Ratio (2.81 vs -0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RXD and IHE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer